William Blair & Company’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$234K Sell
8,497
-1,703
-17% -$47K ﹤0.01% 1358
2025
Q1
$289K Sell
10,200
-15,740
-61% -$446K ﹤0.01% 1271
2024
Q4
$1.08M Sell
25,940
-390
-1% -$16.2K ﹤0.01% 881
2024
Q3
$1.76M Sell
26,330
-170
-0.6% -$11.4K 0.01% 745
2024
Q2
$3.15M Sell
26,500
-4,815
-15% -$572K 0.01% 582
2024
Q1
$3.34M Sell
31,315
-3,601
-10% -$384K 0.01% 565
2023
Q4
$3.47M Sell
34,916
-6,369
-15% -$633K 0.01% 542
2023
Q3
$4.26M Sell
41,285
-4,657
-10% -$481K 0.02% 471
2023
Q2
$5.58M Buy
45,942
+29,043
+172% +$3.53M 0.02% 418
2023
Q1
$2.6M Buy
16,899
+1,306
+8% +$201K 0.01% 596
2022
Q4
$2.8M Buy
15,593
+822
+6% +$148K 0.01% 555
2022
Q3
$1.75M Buy
14,771
+20
+0.1% +$2.37K 0.01% 646
2022
Q2
$2.11M Sell
14,751
-860
-6% -$123K 0.01% 624
2022
Q1
$2.69M Buy
15,611
+1,724
+12% +$297K 0.01% 620
2021
Q4
$3.53M Buy
13,887
+590
+4% +$150K 0.01% 573
2021
Q3
$5.12M Buy
13,297
+448
+3% +$172K 0.02% 452
2021
Q2
$3.02M Sell
12,849
-5,973
-32% -$1.4M 0.01% 589
2021
Q1
$2.47M Buy
18,822
+3,529
+23% +$462K 0.01% 620
2020
Q4
$1.6M Sell
15,293
-1,790
-10% -$187K 0.01% 711
2020
Q3
$1.21M Buy
17,083
+1,022
+6% +$72.3K 0.01% 706
2020
Q2
$1.03M Buy
+16,061
New +$1.03M ﹤0.01% 713